4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling
Abstract Background Septic acute kidney injury (S-AKI) is the leading form of acute kidney failure among hospitalized patients, and the inflammatory response is involved in this process. 4-octyl itaconate (4-OI) is a multi-target itaconate derivative with potent anti-inflammatory action. However, it...
Main Authors: | Lujun Xu, Juan Cai, Chenrui Li, Ming Yang, Tongyue Duan, Qing Zhao, Yiyun Xi, Liya Sun, Liyu He, Chengyuan Tang, Lin Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10020-023-00631-8 |
Similar Items
-
Mechanisms underlying the therapeutic effects of 4-octyl itaconate in treating sepsis based on network pharmacology and molecular docking
by: Maolin Chen, et al.
Published: (2022-11-01) -
4-Octyl itaconate attenuates glycemic deterioration by regulating macrophage polarization in mouse models of type 1 diabetes
by: Sunyue He, et al.
Published: (2023-03-01) -
4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer
by: Wenchang Yang, et al.
Published: (2023-03-01) -
Four-octyl itaconate activates Keap1-Nrf2 signaling to protect neuronal cells from hydrogen peroxide
by: Hua Liu, et al.
Published: (2018-11-01) -
4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients
by: Chun Tang, et al.
Published: (2018-11-01)